Hydraulic sheet metal bending machine is a machine tool controlled by a combination of hydraulic and electrical systems, which is used to perform a one-time bending of sheet metal. It uses a simple mo…
Nintedanib Ethanesulfonate (also known as Nintedanib Esylate) is the ethanesulfonate salt form of nintedanib, an oral triple angiokinase inhibitor used primarily for the treatment of progressive fibro…
Midostaurin is an oral, first-generation, multi-targeted kinase inhibitor that potently inhibits FLT3, KIT, and other kinases, used in combination with chemotherapy for the treatment of newly diagnose…
Midostaurin is an oral, first-generation, multi-targeted kinase inhibitor that potently inhibits FLT3, KIT, and other kinases, used in combination with chemotherapy for the treatment of newly diagnose…
Lapatinib is an oral, small-molecule, reversible tyrosine kinase inhibitor that dually targets the epidermal growth factor receptor (EGFR/HER1) and human epidermal growth factor receptor 2 (HER2/ERBB2…
Vismodegib is an oral, first-in-class, small-molecule inhibitor of the Hedgehog signaling pathway, used for the treatment of locally advanced or metastatic basal cell carcinoma.
Vandetanib is an oral, once-daily, small-molecule inhibitor of multiple tyrosine kinases, including vascular endothelial growth factor receptor (VEGFR), epidermal growth factor receptor (EGFR), and re…
Erlotinib hydrochloride is the hydrochloride salt of erlotinib, an oral, first-generation, reversible tyrosine kinase inhibitor that selectively targets the epidermal growth factor receptor (EGFR), us…
Tucatinib is an oral, highly selective, small-molecule inhibitor of the HER2 tyrosine kinase, used in combination with trastuzumab and capecitabine for the treatment of advanced HER2-positive breast c…
Selitrectinib is an investigational, oral, next-generation, highly selective TRK kinase inhibitor, specifically designed to overcome acquired resistance to prior TRK inhibitor therapy, particularly th…
ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea